WHO: All Forms of Contraception OK for Women at High HIV Risk

Women at high risk for HIV infection can use any form of reversible hormonal contraception without any restrictions, including progestogen-only injectables, implants, and intrauterine devices (IUDs), the World Health Organization (WHO) said.

Emergency departments are a ‘hotspot’ for HIV test-and-treat in South Africa

High HIV prevalence and attrition along the treatment cascade among emergency department (ED) populations highlights potential role of HIV services in theses settings.

Can an immune strategy used to treat cancer also wipe out HIV infections?

Drugs work stunningly well to control HIV—but not in everyone, and not without side effects. That's why a small cadre of patients known as elite controllers has long fascinated researchers: Their immune system alone naturally suppresses HIV for decades without drugs.

Cash payments to stay in school reduce HIV incidence in girls and young women, eSwatini study finds

Financial incentives to remain in school reduced HIV incidence among adolescent girls and young women in eSwatini (Swaziland) by 21%, and participants exposed to both financial incentives and a lottery open only to those who remained free of sexually transmitted infections (STIs) were 37% less li

Dolutegravir safety in pregnancy: risk is lower than first reported

Exposure to dolutegravir at the time of conception or during the first three months of pregnancy is associated with a small increased risk of neural tube defects, longer-term follow-up of a national birth cohort in Botswana has found.

New antiretroviral drug given the thumbs-up by HIV researchers

The new drug is cheaper — and lower costs are expected to make it easier for government to scale up its antiretroviral treatment to ensure that the more than seven million people in South African living with HIV are able to access treatment.

The impact of Mozambique's cyclones on its HIV population

When Cyclone Idai hit Mozambique’s coastal city of Beira in March, heavy winds and torrential rain tore off roofs and destroyed buildings across the city.

Pivotal ECHO Study Provides Reassuring Evidence on HIV Risk and Contraceptives

Results of a pivotal clinical trial among 7,829 women ages 16-35 in East and Southern Africa provide important evidence to help inform women’s choices for contraception and HIV prevention. The Evidence for Contraceptive Options and HIV Outcomes (ECHO) Study found no substantial difference in HIV risk among women using the three methods of contraception in the study – the copper-releasing intrauterine device (Cu-IUD), a levonorgestrel (LNG) implant (Jadelle) and depot medroxyprogesterone acetate-intramuscular (DMPA-IM), also known as Depo-Provera.

Botswana: Decriminalisation of consensual same sex relations should inspire other African countries

Today’s judgement by the Gaborone High Court to decriminalize consensual same sex relations is a victory in the battle for equality and freedom to love whoever you choose, Amnesty International said as it called on other African countries to follow Botswana’s inspiring example.

USAID mTaPS Update January 2019

Preventing maternal and child deaths, creating an AIDS-free generation, and protecting communities from infectious disease threats needs efficient pharmaceutical services and treatment with quality medicines.